DK0764273T3 - Alfa B crystallin til anvendelse i diagnose og terapi af autoimmune sygdomme, især multipel sklerose - Google Patents
Alfa B crystallin til anvendelse i diagnose og terapi af autoimmune sygdomme, især multipel skleroseInfo
- Publication number
- DK0764273T3 DK0764273T3 DK95920305T DK95920305T DK0764273T3 DK 0764273 T3 DK0764273 T3 DK 0764273T3 DK 95920305 T DK95920305 T DK 95920305T DK 95920305 T DK95920305 T DK 95920305T DK 0764273 T3 DK0764273 T3 DK 0764273T3
- Authority
- DK
- Denmark
- Prior art keywords
- crystallin
- alpha
- multiple sclerosis
- diagnosis
- therapy
- Prior art date
Links
- 102000013640 alpha-Crystallin B Chain Human genes 0.000 title abstract 5
- 108010051585 alpha-Crystallin B Chain Proteins 0.000 title abstract 5
- 201000006417 multiple sclerosis Diseases 0.000 title abstract 4
- 208000023275 Autoimmune disease Diseases 0.000 title abstract 2
- 238000003745 diagnosis Methods 0.000 title 1
- 238000002560 therapeutic procedure Methods 0.000 title 1
- 239000000427 antigen Substances 0.000 abstract 1
- 230000005784 autoimmunity Effects 0.000 abstract 1
- 238000001514 detection method Methods 0.000 abstract 1
- 238000002405 diagnostic procedure Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 210000005036 nerve Anatomy 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 210000004885 white matter Anatomy 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
- C07K14/7051—T-cell receptor (TcR)-CD3 complex
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Toxicology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Cell Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Rehabilitation Therapy (AREA)
- Rheumatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP94201653 | 1994-06-09 | ||
| PCT/NL1995/000203 WO1995033997A1 (en) | 1994-06-09 | 1995-06-08 | Alpha b crystallin for use in diagnosis and therapy of auto-immune diseases in particular multiple sclerosis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0764273T3 true DK0764273T3 (da) | 1999-06-23 |
Family
ID=8216937
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK95920305T DK0764273T3 (da) | 1994-06-09 | 1995-06-08 | Alfa B crystallin til anvendelse i diagnose og terapi af autoimmune sygdomme, især multipel sklerose |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20100291119A9 (ja) |
| EP (1) | EP0764273B1 (ja) |
| JP (1) | JP3558347B2 (ja) |
| AT (1) | ATE172304T1 (ja) |
| AU (1) | AU696637B2 (ja) |
| CA (1) | CA2192468A1 (ja) |
| DE (1) | DE69505376T2 (ja) |
| DK (1) | DK0764273T3 (ja) |
| ES (1) | ES2125618T3 (ja) |
| WO (1) | WO1995033997A1 (ja) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH10504039A (ja) * | 1994-10-25 | 1998-04-14 | イミユロジク・フアーマシユーチカル・コーポレーシヨン | 多発性硬化症のための組成物および治療法 |
| US6007821A (en) * | 1997-10-16 | 1999-12-28 | Fordham University | Method and compositions for the treatment of autoimmune disease using heat shock proteins |
| US6861403B2 (en) | 2000-05-03 | 2005-03-01 | Expressive Constructs, Inc. | Method and device for improving protein stability and solubility |
| EP1288226A1 (en) * | 2001-09-03 | 2003-03-05 | Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek Tno | Modification of the expression levels of Toll-like receptor familiy members for influencing neurodegeneration and neuroprotection in the human central nervous system |
| WO2005004894A2 (en) * | 2003-05-12 | 2005-01-20 | Expressive Constructs, Inc. | Methods for increasing cell and tissue viability |
| WO2008073466A2 (en) * | 2006-12-11 | 2008-06-19 | The Board Of Trustees Of The Leland Stanford Junior University | Alpha b-crystallin as a therapy for inflammation |
| US8771689B2 (en) | 2006-12-11 | 2014-07-08 | The Board Of Trustees Of The Leland Stanford Junior University | Alpha B-crystallin as a therapy for ischemia or inflammation |
| WO2012008834A1 (en) | 2010-07-16 | 2012-01-19 | Delta Crystallon B.V. | Microparticles comprising a small heat-shock protein |
| US10034915B2 (en) | 2011-06-23 | 2018-07-31 | The Board Of Trustees Of The Leland Stanford Junior University | Small heat shock proteins and active fragments thereof as a therapy for inflammation and ischemia |
| WO2014200345A1 (en) | 2013-06-14 | 2014-12-18 | Delta Crystallon B.V. | Method for antigen-specific tolerance induction in humans using the small heat shock protein alpha b-crystallin. |
| WO2014200346A1 (en) | 2013-06-14 | 2014-12-18 | Delta Crystallon B.V. | Quantification of alpha b-crystallin |
-
1995
- 1995-06-08 DE DE69505376T patent/DE69505376T2/de not_active Expired - Lifetime
- 1995-06-08 JP JP50069396A patent/JP3558347B2/ja not_active Expired - Fee Related
- 1995-06-08 AU AU25799/95A patent/AU696637B2/en not_active Ceased
- 1995-06-08 CA CA002192468A patent/CA2192468A1/en not_active Abandoned
- 1995-06-08 DK DK95920305T patent/DK0764273T3/da active
- 1995-06-08 AT AT95920305T patent/ATE172304T1/de not_active IP Right Cessation
- 1995-06-08 ES ES95920305T patent/ES2125618T3/es not_active Expired - Lifetime
- 1995-06-08 WO PCT/NL1995/000203 patent/WO1995033997A1/en active IP Right Grant
- 1995-06-08 EP EP95920305A patent/EP0764273B1/en not_active Expired - Lifetime
-
2003
- 2003-12-10 US US10/732,586 patent/US20100291119A9/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CA2192468A1 (en) | 1995-12-14 |
| JPH10501888A (ja) | 1998-02-17 |
| AU696637B2 (en) | 1998-09-17 |
| DE69505376D1 (de) | 1998-11-19 |
| US20050013824A1 (en) | 2005-01-20 |
| US20100291119A9 (en) | 2010-11-18 |
| DE69505376T2 (de) | 1999-04-08 |
| ES2125618T3 (es) | 1999-03-01 |
| JP3558347B2 (ja) | 2004-08-25 |
| EP0764273B1 (en) | 1998-10-14 |
| ATE172304T1 (de) | 1998-10-15 |
| WO1995033997A1 (en) | 1995-12-14 |
| AU2579995A (en) | 1996-01-04 |
| EP0764273A1 (en) | 1997-03-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE59705683D1 (de) | IMMUNOLOGISCHES NACHWEISVERFAHREN VON ANTIKÖRPERN, DIE GEGEN GEWEBE-TRANSGLUTAMINASE (tTG) GERICHTET SIND, VERWENDUNG VON tTG ZUR DIAGNOSE UND THERAPIEKONTROLLE SOWIE ORALES PHARMAZEUTISCHES MITTEL ENTHALTEND tTG | |
| DE69532829D1 (de) | Vorrichtung zur benutzung mit einem chirurgischen navigationssystem | |
| DE69631738D1 (de) | Medizinische implantierbare Vorrichtung für elektrochemische Messungen von Bluteigenschaften | |
| DK0559795T3 (da) | Fremgangsmåder til diagnosticering af kroniske smerter i lænderegionen og halshvrivelsøjlen | |
| CY1109868T1 (el) | Cd81 πρωτεϊνη υποδοχεας ηπατιτιδας c | |
| DK0764273T3 (da) | Alfa B crystallin til anvendelse i diagnose og terapi af autoimmune sygdomme, især multipel sklerose | |
| DE69510336T2 (de) | Verfahren zur diagnose von praeklampsie | |
| ATE244299T1 (de) | Test und behandlung von demyelinierenden krankheiten wie multiple sklerosis | |
| ATE210721T1 (de) | Verwendung eines mbp peptides zur herstellung eines medikamentes für die behandlung von multipler sclerose | |
| PT1025849E (pt) | Metodos para deteccao e tratamento de individuos tendo celulas anormais que expressam antigenios do peptideo hla-a2/tirosinase | |
| NO963487L (no) | Isolerte, tyrosinaseavledete peptider, samt anvendelser derav | |
| FI933291A0 (fi) | Foerfarande foer paovisning av anti-rna-antikroppar | |
| DE3879085T2 (de) | Snrnp-a-antigen und fragmente davon. | |
| DE69734890D1 (de) | Rdgb-proteine | |
| FI963170A0 (fi) | Menetelmä solujen poikkeavuudesta kärsivien yksilöiden tunnistamiseks i | |
| IT1283899B1 (it) | Peptidi e loro usi nella terapia della malattia celiaca | |
| ATE316657T1 (de) | Diagnostische und therapeutische verwendung des caps | |
| AU2003215667A1 (en) | Diagnostic and therapeutic use of human maguin proteins and nucleic acids for neurodegenerative diseases |